Literature DB >> 16843448

Brain pH has a significant impact on human postmortem hippocampal gene expression profiles.

S Mexal1, R Berger1, C E Adams1, R G Ross1, R Freedman2, S Leonard3.   

Abstract

Studies of neurobiological disorders in the brain, including schizophrenia, rely on the use of postmortem brain tissues, in which an understanding of the effects of various pre- and postmortem variables on gene expression is critical. In several different brain regions, pH has been shown to have a large effect on postmortem brain gene expression patterns. One region that has not yet been evaluated in such studies is the hippocampus, a region often implicated in schizophrenia research. In the present study, we show that postmortem brain pH is similar across different brain regions. Brain pH accounted for greater variation in hippocampal gene expression profiles than any other parameter evaluated, including gender and schizophrenia. The predictive value of brain pH in an independent sample set was also greater than the disease, demonstrating that pH represents one of the most important control parameters in human postmortem gene expression studies in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16843448     DOI: 10.1016/j.brainres.2006.05.043

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  34 in total

1.  Permutation-based adjustments for the significance of partial regression coefficients in microarray data analysis.

Authors:  Brandie D Wagner; Gary O Zerbe; Sharon Mexal; Sherry S Leonard
Journal:  Genet Epidemiol       Date:  2008-01       Impact factor: 2.135

2.  Histological assessment of cerebellar granule cell layer in postmortem brain; a useful marker of tissue integrity?

Authors:  Donna Sheedy; Antony Harding; Meichien Say; Julia Stevens; Jillian J Kril
Journal:  Cell Tissue Bank       Date:  2011-06-28       Impact factor: 1.522

Review 3.  Better understanding of mechanisms of schizophrenia and bipolar disorder: from human gene expression profiles to mouse models.

Authors:  Chi-Ying Lin; Akira Sawa; Hanna Jaaro-Peled
Journal:  Neurobiol Dis       Date:  2011-09-03       Impact factor: 5.996

Review 4.  Gene expression in the human brain: the current state of the study of specificity and spatiotemporal dynamics.

Authors:  Oksana Yu Naumova; Maria Lee; Sergei Yu Rychkov; Natalia V Vlasova; Elena L Grigorenko
Journal:  Child Dev       Date:  2012-11-12

5.  An International Survey of Brain Banking Operation and Characterization Practices.

Authors:  Beatrix Palmer-Aronsten; Donna Sheedy; Toni McCrossin; Jillian Kril
Journal:  Biopreserv Biobank       Date:  2016-07-11       Impact factor: 2.300

Review 6.  Brain expression quantitative trait locus mapping informs genetic studies of psychiatric diseases.

Authors:  Chunyu Liu
Journal:  Neurosci Bull       Date:  2011-04       Impact factor: 5.203

7.  Comorbidities, confounders, and the white matter transcriptome in chronic alcoholism.

Authors:  Greg T Sutherland; Donna Sheedy; Pam J Sheahan; Warren Kaplan; Jillian J Kril
Journal:  Alcohol Clin Exp Res       Date:  2014-01-24       Impact factor: 3.455

8.  Age-related changes of gene expression in the neocortex: preliminary data on RNA-Seq of the transcriptome in three functionally distinct cortical areas.

Authors:  Oksana Yu Naumova; Dean Palejev; Natalia V Vlasova; Maria Lee; Sergei Yu Rychkov; Olga N Babich; Flora M Vaccarino; Elena L Grigorenko
Journal:  Dev Psychopathol       Date:  2012-11

9.  The alternative splicing of the apolipoprotein E gene is unperturbed in the brains of Alzheimer's disease patients.

Authors:  James D Mills; Pamela J Sheahan; Donna Lai; Jillian J Kril; Michael Janitz; Greg T Sutherland
Journal:  Mol Biol Rep       Date:  2014-07-05       Impact factor: 2.316

10.  Regulation of a novel alphaN-catenin splice variant in schizophrenic smokers.

Authors:  Sharon Mexal; Ralph Berger; Lucy Pearce; Amanda Barton; Judy Logel; Catherine E Adams; Randal G Ross; Robert Freedman; Sherry Leonard
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-09-05       Impact factor: 3.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.